We are live on
!
Find out more
PFO
Pathstone Family Office Portfolio holdings
AUM
$13.1B
1-Year Est. Return
21.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.66%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$786M
AUM Growth
+$437M
(+125%)
Cap. Flow
+$384M
Cap. Flow
% of AUM
48.81%
Top 10 Holdings %
Top 10 Hldgs %
60.73%
Holding
976
New
432
Increased
206
Reduced
50
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$67.9M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$40.6M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$23.8M |
| 4 |
EFOR
Everforth Inc
EFOR
|
+$22.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.07M |
| 2 |
UroGen Pharma
URGN
|
+$1.67M |
| 3 |
PayPal
PYPL
|
+$752K |
| 4 |
Allogene Therapeutics
ALLO
|
+$713K |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
+$682K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.68% |
| 2 | Technology | 11.41% |
| 3 | Consumer Discretionary | 7.86% |
| 4 | Industrials | 4.27% |
| 5 | Communication Services | 4.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CACI
CACI
$11.4B
| $2K | ﹤0.01% |
+13
| New | +$2.21K |
|
752
Cars.com
CARS
$662M
| $2K | ﹤0.01% |
94
| – | – |
|
|
CMA
753
DELISTED
Comerica
CMA
| $2K | ﹤0.01% |
31
| – | – |
|
754
Quest Diagnostics
DGX
$26B
| $2K | ﹤0.01% |
24
-1,676
| -99% | -$145K |
|
755
Delek US
DK
$3.66B
| $2K | ﹤0.01% |
54
-558
| -91% | -$19K |
|
756
Enovis
ENOV
$1.74B
| $2K | ﹤0.01% |
+45
| New | +$1.97K |
|
757
Entegris
ENTG
$22.2B
| $2K | ﹤0.01% |
+61
| New | +$2.03K |
|
|
ESPR
758
DELISTED
Esperion Therapeutics
ESPR
| $2K | ﹤0.01% |
60
| – | – |
|
759
Evolent Health
EVH
$346M
| $2K | ﹤0.01% |
+142
| New | +$2.25K |
|
760
Edwards Lifesciences
EW
$51.2B
| $2K | ﹤0.01% |
39
-2,238
| -98% | -$128K |
|
761
Fastenal
FAST
$57.4B
| $2K | ﹤0.01% |
+96
| New | +$1.45K |
|
|
FITB
762
Fifth Third Bancorp
FITB
$52.2B
| $2K | ﹤0.01% |
+63
| New | +$1.68K |
|
763
G-III Apparel Group
GIII
$1.54B
| $2K | ﹤0.01% |
+57
| New | +$1.98K |
|
764
Granite Construction
GVA
$5.4B
| $2K | ﹤0.01% |
57
| – | – |
|
765
Guidewire Software
GWRE
$13.3B
| $2K | ﹤0.01% |
+20
| New | +$1.79K |
|
766
Hyatt Hotels
H
$16.9B
| $2K | ﹤0.01% |
+24
| New | +$1.7K |
|
767
Helen of Troy
HELE
$689M
| $2K | ﹤0.01% |
+21
| New | +$2.42K |
|
768
Helmerich & Payne
HP
$3.33B
| $2K | ﹤0.01% |
44
| – | – |
|
769
ICF International
ICFI
$1.54B
| $2K | ﹤0.01% |
+28
| New | +$1.98K |
|
770
ICU Medical
ICUI
$4.16B
| $2K | ﹤0.01% |
+8
| New | +$1.92K |
|
771
Idexx Laboratories
IDXX
$46.1B
| $2K | ﹤0.01% |
+8
| New | +$1.65K |
|
772
IMAX
IMAX
$2.78B
| $2K | ﹤0.01% |
+84
| New | +$1.79K |
|
|
773
iShares Russell Mid-Cap ETF
IWR
$57B
| $2K | ﹤0.01% |
44
-13,156
| -100% | -$682K |
|
774
Kadant
KAI
$3.98B
| $2K | ﹤0.01% |
+28
| New | +$2.41K |
|
775
Korn Ferry
KFY
$4.25B
| $2K | ﹤0.01% |
+39
| New | +$1.78K |
|
Similar funds
CG
API
TA
SCH
PWAG
CS
IWP
MAM
Pathstone Family Office's Q1 2019 Portfolio in Review
As of Q1 2019, Pathstone Family Office held 976 positions worth $786M, up 125% from $349M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Pathstone Family Office deployed $384M of net new capital in Q1 2019, opening 432 new positions and adding to 206 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 232,515 shares worth $12M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $2.07M trimmed.
- Pathstone Family Office's largest Q1 2019 buy was iShares Core MSCI Emerging Markets ETF: 232,515 shares worth $12M.
- Pathstone Family Office added most to Vanguard Morningstar Total Stock Market ETF in Q1 2019, an estimated $67.9M increase.
- Pathstone Family Office's biggest Q1 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.07M.
- Pathstone Family Office fully exited UroGen Pharma in Q1 2019, selling an estimated $1.67M.
- Pathstone Family Office's ten largest holdings make up 61% of its $786M portfolio in Q1 2019.
- Pathstone Family Office opened 432 new positions and closed 63 in Q1 2019.
- Pathstone Family Office's portfolio value rose 125% quarter-over-quarter to $786M.
Based on Pathstone Family Office's 13F filing for Q1 2019, filed 14 May 2019.